HopeStage
Back to all studies
RecruitingNCT06484075

Suvorexant or placebo and brain dopamine in people with alcohol use

About this titleRead the official source — NCT06484075
Medication studyAges 18–75United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

What will I do during this study?

Participants receiving alcohol-withdrawal treatment stay on the clinical unit and are assigned suvorexant or placebo (an inactive comparison treatment) alongside usual care, with movement monitoring, blood tests and thinking assessments. Brain imaging includes two PET scans and one MRI (magnetic resonance imaging). Healthy volunteers form a separate imaging group without study treatment.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 21, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
180
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Device, Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT06484075
Official title
Show the full official title

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

Recruitment & locations

Currently recruiting

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.

Does this study involve medication?

Yes. The study involves medication, including Suvorexant and Placebo.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies